Peripheral blood stem cell transplants.
作者信息
Byrne J L, Russell N H
机构信息
Department of Haematology, City Hospital, Nottingham, UK.
出版信息
J Clin Pathol. 1998 May;51(5):351-5. doi: 10.1136/jcp.51.5.351.
Abstract
摘要
相似文献
1
Peripheral blood stem cell transplants.外周血干细胞移植。
J Clin Pathol. 1998 May;51(5):351-5. doi: 10.1136/jcp.51.5.351.
2
3
Current status of stem cell mobilization.干细胞动员的现状。
Br J Haematol. 2010 Sep;150(6):647-62. doi: 10.1111/j.1365-2141.2010.08313.x.
4
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
Leuk Lymphoma. 2013 Feb;54(2):417-20. doi: 10.3109/10428194.2012.702901. Epub 2012 Jul 9.
5
Bone marrow and peripheral blood stem cell transplantation for malignancy.
Health Technol Assess. 1998;2(8):1-187.
6
Stem cell mobilization: the other side of the coin: commentary on the current status of stem cell mobilization.干细胞动员：硬币的另一面：关于干细胞动员现状的评论
Br J Haematol. 2010 Sep;150(6):663-4. doi: 10.1111/j.1365-2141.2010.08311.x.
7
[Bases of bone marrow transplantation: modalities and indications].
Rev Clin Esp. 1999 Apr;199 Suppl 1:14-21.
8
Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.超越 CD34+ 细胞剂量：外周血造血干细胞动员方法（粒细胞集落刺激因子[G-CSF]、G-CSF 加plerixafor 或环磷酰胺 G-CSF/粒细胞-巨噬细胞[GM]-CSF）对集落形成单位-GM 数量、植入和第 100 天造血移植物功能的影响。
Transfusion. 2011 Sep;51(9):1995-2000. doi: 10.1111/j.1537-2995.2011.03085.x. Epub 2011 Mar 10.
9
Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).成年多发性骨髓瘤和淋巴瘤患者的自体造血祖细胞动员与采集：土耳其单采协会（TSA）的立场声明
Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10.
10
Utilization study of filgrastim (Neutromax) during autologous haematopoietic precursor transplantation for myeloma and lymphoma patients.非格司亭（Neutromax）在骨髓瘤和淋巴瘤患者自体造血前体细胞移植中的应用研究。
Transfus Apher Sci. 2009 Oct;41(2):87-93. doi: 10.1016/j.transci.2009.07.007. Epub 2009 Aug 20.
引用本文的文献
1
Stem cell technology. Interview by Abi Berger.干细胞技术。阿比·伯杰访谈。
BMJ. 1999 Nov 13;319(7220):1308. doi: 10.1136/bmj.319.7220.1308.
本文引用的文献
1
Allogeneic blood stem cell transplantation: considerations for donors.异基因造血干细胞移植：供者相关考量
Blood. 1997 Aug 1;90(3):903-8.
2
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.难治性或复发性淋巴瘤中的干细胞动员：与中等剂量环磷酰胺相比，包含异环磷酰胺、依托泊苷和表柔比星的挽救方案后祖细胞产量更高。
Br J Haematol. 1997 Jul;98(1):228-33. doi: 10.1046/j.1365-2141.1997.1812998.x.
3
4
5
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study.
J Clin Oncol. 1997 Jun;15(6):2288-95. doi: 10.1200/JCO.1997.15.6.2288.
6
7
Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.霍奇金淋巴瘤和非霍奇金淋巴瘤中，外周血干细胞移植与自体骨髓移植的比较：欧洲血液与骨髓移植登记处数据的一项新配对分析。欧洲血液与骨髓移植淋巴瘤工作组
J Clin Oncol. 1997 Feb;15(2):509-17. doi: 10.1200/JCO.1997.15.2.509.
8
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.低剂量非格司亭显著提高了淋巴增生性疾病患者自体外周血干细胞移植后的中性粒细胞恢复：临床和经济效益的证据。
J Clin Oncol. 1997 Feb;15(2):451-7. doi: 10.1200/JCO.1997.15.2.451.
9
Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).1995年欧洲的血液与骨髓移植活动。欧洲血液与骨髓移植组（EBMT）
Bone Marrow Transplant. 1997 Mar;19(5):407-19. doi: 10.1038/sj.bmt.1700694.
10
Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk.异基因外周血干细胞移植治疗血液系统恶性肿瘤——植入动力学及移植物抗宿主病风险分析
Bone Marrow Transplant. 1997 Jan;19(1):9-13. doi: 10.1038/sj.bmt.1700603.
Zotero 插件